[Intravenous clomipramine for depressive disorders].

[Intravenous clomipramine for depressive disorders].

Mostra altre versioni (1)

51 patients with depressive episode (40--recurrent depressive disorder, 11--bipolar affective disorder) were treated by the clomipramine intravenous infusions. The number of infusions varied from 5 to 21 (mostly 10-16). The median of maximal dose was 150 mg. There were significant clinical improveme...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Landowski, J, Lamparska, E, Wichowicz, H, Gizińska, D, Godlewska, B, Wiglusz, M
Natura:	Journal article
Lingua:	Polish
Pubblicazione:	2002

Documenti analoghi

Intravenous clomipramine for depressive disorders
di: Landowski, J, et al.
Pubblicazione: (2002)

The utility of intravenous clomipramine in a case of Cotard's syndrome
di: Rui Lopes, et al.
Pubblicazione: (2013-06-01)

Delusional depression responding to clomipramine in Binswanger's disease.
di: Turkington, D, et al.
Pubblicazione: (1990)

Clomipramine for Compulsive Tics
di: J Gordon Millichap
Pubblicazione: (1994-08-01)

In Vitro/In Vivo Evaluation of Clomipramine Orodispersible Tablets for the Treatment of Depression and Obsessive-Compulsive Disorder
di: Shazia Akram Ghumman, et al.
Pubblicazione: (2023-02-01)

NEONATAL TREATMENT WITH CLOMIPRAMINE AND DEPRESSION: A REVIEW OF BEHAVIORAL AND PHYSIOLOGICAL FINDINGS
di: NADIA JUSTEL, et al.
Pubblicazione: (2011-01-01)

Clomipramine Misuse in a Patient with Schizophrenia
di: Mehmet Ünler, et al.
Pubblicazione: (2023-04-01)

Chronic clomipramine treatment reverses core symptom of depression in subordinate tree shrews.
di: Jing Wang, et al.
Pubblicazione: (2013-01-01)

Clomipramine, clomiphene, and generic drug-dispensing errors
di: Amar Bavle, et al.
Pubblicazione: (2016-01-01)

Indicators of the persistent pro-inflammatory activation of the immune system in depression
di: Cubała, W, et al.
Pubblicazione: (2006)

[Indicators of the persistent pro-inflammatory activation of the immune system in depression].
di: Cubała, W, et al.
Pubblicazione: (2006)

Clomipramine trial for treatment-resistant persistent genital arousal disorder: a case series
di: Ejder Akgun Yildirim, et al.
Pubblicazione: (2017-10-01)

Comparing the Effects of Clomipramine and Fluoxetine on Fasting Blood Glucose in Children With Obsessive-Compulsive Disorder
di: Reza Torkzaban, et al.
Pubblicazione: (2006-04-01)

Clomipramine Induced Extrapyramidal Symptoms: A Case Series
di: Disha Mukherjee, et al.
Pubblicazione: (2023-04-01)

Does treatment with clomipramine reduce cat psychogenic alopecia?
di: Anne-Claude Griesser
Pubblicazione: (2022-06-01)

Clomipramine enhances prolactin and growth hormone responses to L-tryptophan.
di: Anderson, I, et al.
Pubblicazione: (1986)

Comparing the effectiveness of clomipramine and fluoxetine in dogs with anxiety-related behaviours
di: Olivia Williamson, et al.
Pubblicazione: (2024-03-01)

Effeciveness of Citalopram, Alprazolam and Clomipramine in Amelioration of Negative Sympotoms in Schizphrenia
di: Saeed Shoja'-Shafti
Pubblicazione: (2003-04-01)

The Tricyclic Antidepressant Clomipramine Increases Plasma Glucose Levels of Mice
di: Yumi Sugimoto, et al.
Pubblicazione: (2003-01-01)

Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment
di: K Miguita, et al.
Pubblicazione: (2011-01-01)

Clinical Correlates of Rapid Eyeball Movement Sleep Behaviour Disorder with Clomipramine: A Case Control Study
di: Abhinav Pandey, et al.
Pubblicazione: (2020-11-01)

The bio-distribution of the antidepressant clomipramine is modulated by chronic stress in mice: Effects on behavior
di: Georgia eBalsevich, et al.
Pubblicazione: (2015-01-01)

Erratum to: Comparing the effectiveness of clomipramine and fluoxetine in dogs with anxiety-related behaviours
di: Olivia Williamson, et al.
Pubblicazione: (2024-06-01)

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine.
di: Whale, R, et al.
Pubblicazione: (2000)

Cardiac electrophysiological effects of citalopram in guinea pig papillary muscle comparison with clomipramine.
di: Pacher, P, et al.
Pubblicazione: (2000)

Refractory Hypotension after Tourniquet Deflation in a Patient on Chronic Clomipramine Therapy
di: Pradeep Govil, et al.
Pubblicazione: (2008-01-01)

Determination of Clomipramine using eco-friendly solid-contact ionophore-doped potentiometric sensor
di: Adel M. Michael, et al.
Pubblicazione: (2023-03-01)

Intravenous Ketamine Infusions in Treatment-Resistant Bipolar Depression: An Open-Label Naturalistic Observational Study
di: Wilkowska A, et al.
Pubblicazione: (2021-08-01)

The Role of Clomipramine in Potentiating the Teratogenic Effects of Caffeine in Pregnant Rats: A Histopathological Study
di: Vahid Nikoui, et al.
Pubblicazione: (2013-01-01)

CLOMIPRAMINE AS DAILY DOSE IN THE TREATMENT OF PATIENTS WITH PREMATURE EJACULATION: PROSPECTIVE PLACEBO- CONTROLLED STUDY
di: Majid A Mohammed
Pubblicazione: (2007-06-01)

Tolerability and Optimal Therapeutic Dosage of Clomipramine for Premature Ejaculation: A Systematic Review and Meta-Analysis
di: Po-Chien Wu, MD, et al.
Pubblicazione: (2021-02-01)

Depressive disorders and intravenous drug use in chemsex context
di: J. Curto Ramos, et al.
Pubblicazione: (2024-04-01)

Clomipramine enhances the cortisol response to 5-HTP: implications for the therapeutic role of 5-HT2 receptors.
di: Sargent, P, et al.
Pubblicazione: (1998)

Acute clomipramine exposure elicits dose-dependent surfacing behavior in adult zebrafish (Danio rerio)
di: Adeel Shafiq, et al.
Pubblicazione: (2024-07-01)

The Effect of Clomipramine on Spermatogenesis Process, and Testosterone, Follicle Stimulating, and Luteinizing Hormone in Laboratory Male Rats
di: Akbar Karimi, et al.
Pubblicazione: (2018-07-01)

Chronic clomipramine treatment reverses depressogenic-like effects of a chronic treatment with dexamethasone in rats
di: Abderrahim Laaziz, et al.
Pubblicazione: (2022-12-01)

Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress
di: Shanshan Zhang, et al.
Pubblicazione: (2022-06-01)

Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic
di: Simon Faissner, et al.
Pubblicazione: (2017-12-01)

Amitriptyline, clomipramine, and maprotiline attenuate the inflammatory response by inhibiting neutrophil migration and mast cell degranulation
di: José Alves Gurgel, et al.
Pubblicazione: (2013-12-01)

Endoscopic removal of a gastric pharmacobezoar induced by clomipramine, lorazepam, and domperidone overdose: a case report
di: Stephan von Düring, et al.
Pubblicazione: (2019-02-01)